Rhodococcus Equi Antibody Optimization

About MG Biologics

MG Biologics is a private veterinary biologics company founded in 2012 (with roots dating to 1999) and headquartered in Ames, Iowa. It operates a commercial-stage business model, manufacturing and selling a portfolio of hyperimmune plasma and antibody products for livestock and companion animals, with key offerings for Clostridium perfringens, tetanus, Rhodococcus equi, and snake envenomation. The company leverages a donor herd platform to produce targeted antibody therapies, emphasizing custom blends and research-backed formulations to reduce disease severity in animals.

Therapeutic Areas